5 results
8-K
EX-99.1
INVA
Innoviva Inc
24 May 23
Corporate Presentation May 2023
5:18pm
, composed of widely used respiratory therapies commercialized by GSK, have produced durable, resilient revenues that are de - risked via geographic and drug
8-K
EX-99.1
INVA
Innoviva Inc
14 Sep 22
Regulation FD Disclosure
5:22pm
Sizeable and differentiated Resilient anddurable Diversifiedand established Differentiated respiratory portfolio with over $2B 2021 sales (for Breo and Anoro
8-K
EX-99.1
INVA
Innoviva Inc
7 Apr 22
Regulation FD Disclosure
5:09pm
the next generation of high impact products Sizeable and differentiated Resilient anddurable Diversifiedand growing Differentiated respiratory
8-K
EX-99.1
INVA
Innoviva Inc
13 Dec 21
Corporate Presentation December 2021
4:39pm
while we build out the next generation of high impact products Sizeable and differentiated Resilient and durable Diversified and growing Differentiated
- Prev
- 1
- Next